Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 comparison of vonoprazan-based vs lansoprazole-based triple therapy for first-line H. pylori eradication
jRCT2080221680Phase 3
- Sponsor
- Takeda
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of vonoprazan in Helicobacter pylori infection and Peptic ulcer disease (PUD) (2 arms), sponsored by Takeda.
02
Drugs
vonoprazan
03
Conditions
Helicobacter pylori infectionPeptic ulcer disease (PUD)
Beyond the preview
Go deeper on jRCT2080221680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221680.